# C_2022388EN.01000901.xml

| 10.10.2022 | EN | Official Journal of the European Union | C 388/9 |
| --- | --- | --- | --- |

10.10.2022

EN

Official Journal of the European Union

C 388/9

---

Prior notification of a concentration

(Case M.10893 – QUATTROR / IMTC / MTD)

Candidate case for simplified procedure

(Text with EEA relevance)

(2022/C 388/08)

1.

This notification concerns the following undertakings:

| — | QuattroR SGR S.p.A. (‘QuattroR’, Italy), |
| --- | --- |

—

QuattroR SGR S.p.A. (‘QuattroR’, Italy),

| — | International Medical Technology Collective S.C.A. (‘IMTC’, Luxembourg), controlled by Investindustrial S.A. (‘Investindustrial’, Luxembourg), |
| --- | --- |

—

International Medical Technology Collective S.C.A. (‘IMTC’, Luxembourg), controlled by Investindustrial S.A. (‘Investindustrial’, Luxembourg),

| — | Medical Technology and Devices SA (‘MTD’, Switzerland). |
| --- | --- |

—

Medical Technology and Devices SA (‘MTD’, Switzerland).

QuattroR and IMTC will acquire within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control of MTD.

The concentration is accomplished by way of purchase of shares.

2.

| — | QuattroR manages an Italian private equity fund and currently controls five portfolio companies in the area of engineering, logistics and manufacturing, |
| --- | --- |

—

QuattroR manages an Italian private equity fund and currently controls five portfolio companies in the area of engineering, logistics and manufacturing,

| — | IMTC is an investment subsidiary of Investindustrial, an investment group focusing on consumer and leisure, healthcare and services, industrial manufacturing and technology, |
| --- | --- |

—

IMTC is an investment subsidiary of Investindustrial, an investment group focusing on consumer and leisure, healthcare and services, industrial manufacturing and technology,

| — | MTD, a Swiss-based med-tech group that designs, develops, and provides globally medical devices, particularly diabetes management devices, standard and safety sharp devices, electro-medical devices and wound-care products. |
| --- | --- |

—

MTD, a Swiss-based med-tech group that designs, develops, and provides globally medical devices, particularly diabetes management devices, standard and safety sharp devices, electro-medical devices and wound-care products.

3.

Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.10893 – QUATTROR / IMTC / MTD

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

Email: COMP-MERGER-REGISTRY@ec.europa.eu

Fax +32 22964301

Postal address:

| European Commission |
| --- |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

1

(2)  OJ C 366, 14.12.2013, p. 5.

2

---